SCHEMBL6829699

SCHEMBL6829699

CN1CCN(Cc2cc3ccccc3n2S(=O)(=O)c2ccccc2Br)CC1

nearest known ligand 0.60

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 20/20 0.60
CYP3A4 P08684 2/20 0.55
CYP2D6 P10635 2/20 0.55
ADRA2A P08913 1/20 0.50
ADRA2C P18825 1/20 0.50
HTR2A P28223 1/20 0.50
CYP2C19 P33261 1/20 0.50
CHRM1 P11229 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6830157 0.87 HTR6 (0.59) HTR6CYP3A4CYP2D6ADRA2AADRA2C
SCHEMBL6830687 0.83 HTR6 (0.57) HTR6CYP3A4CYP2D6
SCHEMBL6829345 0.80 HTR6 (0.62) HTR6CYP3A4CYP2D6
SCHEMBL6924345 0.78 HTR6 (0.59) HTR6CYP3A4CYP2D6HTR2A
SCHEMBL6829943 0.76 HTR6 (0.46) HTR6CYP3A4CYP2D6CYP2C19
SCHEMBL6826804 0.76 HTR6 (0.61) HTR6CYP3A4CYP2D6ADRA2AADRA2C
SCHEMBL7086820 0.76 HTR6 (0.55) HTR6CYP3A4CYP2D6CHRM1
SCHEMBL3223044 0.75 HTR6 (1.00) HTR6CYP3A4CYP2D6ADRA2AADRA2C
SCHEMBL3561901 0.75 ACLY (0.46) HTR6CHRM1
SCHEMBL6829316 0.74 HTR6 (0.51) HTR6CYP3A4CYP2D6ADRA2AADRA2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004108671-A1 SUBSTITUTED INDOLES WITH SEROTONIN RECEPTOR AFFINITY, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SUVEN LIFE SCIENCES LIMITED (IN) 2004-12-16 WO claimed
WO-2004108671-A1 SUBSTITUTED INDOLES WITH SEROTONIN RECEPTOR AFFINITY, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SUVEN LIFE SCIENCES LIMITED (IN) 2004-12-16 WO disclosed